Private Equity Dedicated to Longevity & Hormonal Health
Delivering exceptional outcomes for investors and the future of healthcare.
About PEAL Capital
We Partner With Management Teams to Unlock Hidden Value
PEAL Capital is a Europe-based private equity firm focused on the longevity and hormones sector, investing across Western Europe, the UK, and North America. We take controlling or influential minority positions in mature lower-mid-cap businesses and deliver hands-on operational and financial support from acquisition through exit.
Year of
Experience
65+ years combined industry expertise
58 direct investments sourced and managed
2.27× average multiple on cost
Our Mission
To deliver strong, risk-adjusted returns by investing in secondary direct opportunities where our operational expertise and strategic oversight can unlock hidden value and accelerate growth.
Our Values
We believe in disciplined execution, full alignment with management teams, and long-term, sustainable growth. We are committed to integrity, transparency and building lasting partnerships.
Reasons to Choose Us
Why Investors Choose PEAL Capital
As the only private equity firm dedicated exclusively to the longevity and hormones sector, PEAL deploys a three-fund strategy that spans the entire supply chain, securing proprietary off-market opportunities and giving investors full-spectrum exposure.
Proprietary deal flow via trusted networks
Deep due diligence based on live portfolio data, not projections
Hands-on value creation through board-level involvement
Targeted exit strategies with reduced holding periods
Strong alignment with management and investors
Track record of consistent, risk-adjusted returns
AUM
Deal Size Range
Active Governance
Founder Experience
Meet Our Team
A Trusted Team With Decades of Investment and Operational Experience
Karen O'Mahony
Founder & Managing Partner
Brendan McDonagh
Chair of PEAL Capital Group
Tara Mandal
Partner & COO
News
News and Insights From the PEAL Capital Group
DermaHub Launch
On 1st November 2023, Derma Medical launched the world’s first e-learning hub for Aesthetics professionals. DermaHub will be the first of its kind to offer a subscription-based platform that will allow delegates to access the highest-quality online training from...
Carmo Companies Private Markets Texas Conference
Karen O'Mahony and Tara Mandal attended the Carmo Companies Private Markets Texas Conference during the PEAL US roadshow. Karen O'Mahony, Managing Partner and Tara Mandal, Partner and COO thoroughly enjoyed making new connections at Carmo Companies' Private Markets...
TAIC Meet-Up
Karen O'Mahony attends The Alternative Investment Club's Meet-Up, LONGEVITY: Not Only Living Longer but Better PEAL's Managing Partner, Karen O'Mahony, thoroughly enjoyed sharing her insights on Longevity alongside the panel at The Alternative Investment Club's...
PEAL Fund 2nd Investment – GLHMs
PEAL's 2nd portfolio company GLHMs is a medical training company specialising in Longevity, Hormones and Menopause. PEAL Capital Group’s 2nd portfolio company GLHMs is a medical training platform in all areas related to Longevity, Hormones and Menopause. The goal of...